Ftse Mib
33.415,51
-0,89%
DAX
18.147,16
-0,95%
S&P 500
5.475,09
0,27%
NASDAQ
17.879,30
0,83%
Bitcoin
62.579,08
-0,43%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Checkmate Pharmaceuticals Inc (CMPI) Checkmate Pharmaceuticals Inc (CMPI) Notizie

CMPI

Checkmate Pharmaceuticals (CMPI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CMPI
DataOraFonteTitoloSimboloCompagnia
10/06/202214:37Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMPICheckmate Pharmaceuticals Inc
07/06/202217:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
03/06/202217:42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202216:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202215:27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202215:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202215:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202215:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
31/05/202214:38Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
26/05/202223:01GlobeNewswire Inc.University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
12/05/202222:50Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CMPICheckmate Pharmaceuticals Inc
12/05/202222:30GlobeNewswire Inc.Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CMPICheckmate Pharmaceuticals Inc
05/05/202222:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
02/05/202215:17Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CMPICheckmate Pharmaceuticals Inc
02/05/202213:49Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CMPICheckmate Pharmaceuticals Inc
29/04/202222:13Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
20/04/202212:02Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CMPICheckmate Pharmaceuticals Inc
20/04/202205:45TipRanksAnalysts Conflicted on These Healthcare Names: Axsome Therapeutics (AXSM) and Checkmate Pharmaceuticals (CMPI)NASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202222:51Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202215:46Dow Jones NewsCheckmate Pharmaceuticals Shares Take Flight on Regeneron DealNASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202213:47Dow Jones NewsRegeneron to Buy Checkmate Pharmaceuticals for About $250 MillionNASDAQ:CMPICheckmate Pharmaceuticals Inc
19/04/202213:00PR Newswire (US)Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor TypesNASDAQ:CMPICheckmate Pharmaceuticals Inc
12/04/202205:15TipRanksCheckmate Pharmaceuticals (CMPI) Receives a Buy from BTIGNASDAQ:CMPICheckmate Pharmaceuticals Inc
08/04/202219:01GlobeNewswire Inc.Checkmate Pharmaceuticals Presents Clinical Trial Biomarker Data with Vidutolimod at the 2022 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
30/03/202213:22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CMPICheckmate Pharmaceuticals Inc
30/03/202205:06TipRanksAnalysts’ Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Axsome Therapeutics (AXSM)NASDAQ:CMPICheckmate Pharmaceuticals Inc
29/03/202222:30GlobeNewswire Inc.Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business UpdateNASDAQ:CMPICheckmate Pharmaceuticals Inc
08/03/202222:30GlobeNewswire Inc.Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
02/03/202222:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CMPICheckmate Pharmaceuticals Inc
14/02/202217:57Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CMPICheckmate Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CMPI

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
LDO
Leonardo
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
CPR
Davide Campari
BIT
SPM
Saipem
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
FCTAAW
Fincantieri
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network